Identification of a novel HA conformational change inhibitor of human influenza virus

@article{Yoshimoto1999IdentificationOA,
  title={Identification of a novel HA conformational change inhibitor of human influenza virus},
  author={J. N. Yoshimoto and M. Kakui and Hiroshi Iwasaki and Tamaki Fujiwara and Hirohiko Sugimoto and Nachiko Hattori},
  journal={Archives of Virology},
  year={1999},
  volume={144},
  pages={865-878}
}
Stachyflin is a novel compound having H1 and H2 subtype-specific anti-influenza A virus activity. Stachyflin has no inhibition on H3 subtype influenza A or influenza B viruses. The susceptibility of the reassortant viruses between H1 and H3 subtype influenza A viruses to Stachyflin indicated that its target was virus-encoded hemagglutinin (HA). The results of the timing of Stachyflin addition against in vitro virus infection and virus-mediated hemolysis assay suggested that the drug inhibited… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

Investigational hemagglutinin-targeted influenza virus inhibitors.

Expert opinion on investigational drugs • 2017
View 3 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Ltd): Sesquiterpene derivatives having antiviral activity

T Kamigauchi, T Fujiwara, +3 authors Co
PCT WO 9711947A1, April • 1997
View 6 Excerpts
Highly Influenced

Development of antivirals against influenza.

Expert opinion on investigational drugs • 1998
View 1 Excerpt

First total synthesis of ( ±)-Stachyflin

T Taishi, S Takechi, S Mori
Tetrahedron Lett 39: • 1998
View 1 Excerpt

Organic chemistry

AB Holmes, GR Stephenson
Chem Ind • 1998
View 1 Excerpt

Influenza hemagglutinin is spring-loaded by a metastable native conformation.

Proceedings of the National Academy of Sciences of the United States of America • 1997
View 2 Excerpts

Similar Papers

Loading similar papers…